Prior to joining Teva, O’Grady spent 10 years with Sanofi predecessor companies in a variety of commercial and medical affairs roles. In addition to serving on Amwell’s board since 2015, Mr. O’Grady ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results